Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2018Science Translational Medicine

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMohammed SelmanMerck & Co., Inc., Rahway, NJ, USA (United States)POPaula OuUniversity of OttawaCRChristopher RoussoOttawa Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Selman et al. (2018) studied this question.

synapsesocial.com/papers/6aa618130ab0fd924bf4ccc7https://doi.org/10.1126/scitranslmed.aao1613
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Membrane-Proximal Stem Region of Vesicular Stomatitis Virus G Protein Confers Efficient Virus Assembly2000 · 139 citations
  2. 2Interferon‐α and ‐β Restrict Polyomavirus JC Replication in Primary Human Fetal Glial Cells: Implications for Progressive Multifocal Leukoencephalopathy Therapy2007 · 35 citations
  3. 3Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma2015 · 2,673 citations
  4. 4Dimethylfumarate Inhibits TNF-Induced Nuclear Entry of NF-κB/p65 in Human Endothelial Cells2002 · 198 citations
  5. 5Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation2016 · 113 citations